or
forgot password
  • cancer clinical trials in dallas, TX

  • Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Leukemia
    Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
    University of Texas Southwestern Medical Center (Adult)
    Dallas, Texas 75390-8884
    Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure
    Mary Crowley Medical Research Center
    Dallas, Texas 75246
    Carcinoma, Transitional Cell, Bladder Neoplasms
    131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
    Mary Crowley Medical Research Center
    Dallas, Texas 75246
    Malignant Glioma, Glioblastoma Multiforme, GBM, Anaplastic Astrocytoma, Oligo-Astrocytoma, Gliosarcoma
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    Ut Southwestern Medical Center
    Dallas, Texas 75390
    Myeloid Leukemia, Chronic, Chronic-Phase
    Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)
    UT Southwestern
    Dallas, Texas 75390
    Chronic Lymphoproliferative Diseases
    Sirolimus in Treating Patients With Angiomyolipoma of the Kidney
    University of Texas Southwestern Medical Center at Dallas
    Dallas, Texas 75235-8897
    Nonmalignant Neoplasm
    Vaccine Therapy in Treating Patients With Malignant Melanoma
    Simmons Cancer Center at University of Texas Southwestern Medical Center at Dallas
    Dallas, Texas 75390
    Melanoma (Skin)
    Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
    VA North Texas Health Care System, Dallas
    Dallas, Texas 75216
    Prostate Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    University of Texas Southwestern Medical Center
    Localized Osteosarcoma, Metastatic Osteosarcoma
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    Texas Oncology

    Trial Locations
    Texas Oncology
    Texas Cancer Center at Medical City
    The Texas Cancer Center
    Lymphoma, T-Cell, Peripheral
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    University of Texas Southwestern Medical Center

    Trial Locations
    University of Texas Southwestern Medical Center
    Saint Paul Hospital
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
    Texas Oncology, P.A.

    Trial Locations
    Texas Oncology, P.A.
    Center for Oncology Research and Treatment, PA
    Texas Cancer Center ( Medical City Dallas Hospital)
    Texas Oncology, P.A. Presbyterian Hospital
    Texas Oncology, P.A. Sammons Cancer Center
    Texas Oncology, P.A. Texas Oncology PA
    Breast Cancer
    PhII ICb With/Without Erbitux in MBC Pts
    The Texas Cancer Center
    Dallas, Texas 75237
    Metastatic Breast Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Texas Cancer Associates

    Trial Locations
    Texas Cancer Associates
    Texas Hematology Oncology
    Non-Small Cell Lung Cancer
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Leukemia
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    Dallas Surgical Group
    Dallas, Texas 75235
    Melanoma
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Parkland Memorial Hospital

    Trial Locations
    Parkland Memorial Hospital
    Zale Lipshy University Hospital
    University of Texas Southwestern Medical Center
    Saint Paul Hospital
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Saint Paul Hospital
    Dallas, Texas 75235
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
    Mary Crowley Research Center
    Dallas, Texas 75246
    Carcinoid, Neuroendocrine
    Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    Baylor University Medical Center
    Parkland Memorial Hospital
    Zale Lipshy University Hospital
    University of Texas Southwestern Medical Center
    Dallas VA Medical Center
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Parkland Memorial Hospital

    Trial Locations
    Parkland Memorial Hospital
    Zale Lipshy University Hospital
    University of Texas Southwestern Medical Center
    Texas Health Presbyterian Hospital Dallas
    Saint Paul Hospital
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Medical City Dallas Hospital
    Dallas, Texas 75230
    Prostate Cancer